NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis

Atherosclerosis

Volumn 224, Issue 2, 2012, Pages 426-429

  López Mejías, Raquel ^a   García Bermúdez, Mercedes ^b   González Juanatey, Carlos ^c   Castañeda, Santos ^d   Miranda Filloy, José A ^c   Gómez Vaquero, Carmen ^e   Fernández Gutiérrez, Benjamín ^f   Balsa, Alejandro ^g   Pascual Salcedo, Dora ^g   Blanco, Ricardo ^a   González Álvaro, Isidoro ^d   Llorca, Javier ^h   Martín, Javier ^b   González Gay, Miguel A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL XERAL CALDE   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^h UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

94ATTG ins del; Atherosclerosis; Cardiovascular disease; NF kappa B; Rheumatoid arthritis; Rs28362491

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPAIN;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS;

EID: 84866531810     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.06.008     Document Type: Article

References (15)

1. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005, 35:8-17.
2. Dessein P.H., Joffe B.I., Veller M.G., et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005, 32:435-442.
3. Emanuele E. Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises. Atherosclerosis 2011, 216:21-22.
4. Farragher T.M., Goodson N.J., Naseem H., et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 2008, 58:359-369.
5. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Lopez-Diaz M.J., et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007, 57:125-132.
6. Palomino-Morales R., Gonzalez-Juanatey C., Vazquez-Rodriguez T.R., et al. A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 2010, 12:R71.
7. Rodriguez-Rodriguez L., Gonzalez-Juanatey C., Garcia-Bermudez M., et al. CCR5Delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. Arthritis Res Ther 2011, 13:R133.
8. Rodriguez-Rodriguez L., Gonzalez-Juanatey C., Palomino-Morales R., et al. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2011, 216:125-130.
9. Orange J.S., Levy O., Geha R.S. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 2005, 203:21-37.
10. Baldwin A.S. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001, 107:3-6.
11. Marok R., Winyard P.G., Coumbe A., et al. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 1996, 39:583-591.
12. Pereira S.G., Oakley F. Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol 2008, 40:1425-1430.
13. Karban A.S., Okazaki T., Panhuysen C.I., et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004, 13:35-45.
14. Vogel U., Jensen M.K., Due K.M., et al. The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populations. Atherosclerosis 2011, 219:200-204.
15. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.